Acute graft pyelonephritis (AGPN) in renal transplant recipients does not impair long-term graft function, according to Spanish researchers.

Black and Hispanic living kidney donors are at increased relative risk for hypertension, diabetes requiring drug therapy, and CKD compared with their white counterparts, according to researchers.

The risk for CKD is influenced by many factors, some of which depend on how patients are treated before, during, and after transplantation.

Physicians at a New York hospital have been found not liable for the death of a 37-year old man who died from cancer and receiving a kidney from a woman who had uterine cancer.

MUNICH, GERMANY—Urinary tract infections (UTIs) caused by non-coliform bacteria are significantly more common among renal transplant patients compared with the general population, according to a British study.

MUNICH, GERMANY—Live kidney donors may experience an increase in blood pressure following nephrectomy, new data suggest.

A lower dosage strength sirolimus (Rapamune) tablet is now commercially available, according to the drug's maker, Pfizer Inc., of New York.

The increased risk of cancer among renal transplant patients is similar across various immunosuppressant therapies, according to an Australian study published online in the Journal of the American Society of Nephrology.

Novartis Pharmaceuticals, based in East Hanover, NJ, has received FDA approval of Zortress (everolimus) oral tablets for preventing rejection of kidney transplants in adult patients at low-to-moderate immunologic risk.

Particular variations of the CAV1 gene in a kidney donor may determine the success of a kidney transplant. A new analysis uncovered significant differences in graft survival according to donor genotypes of CAV1, which has a role in tissue fibrosis and vascular proliferation.